Susan B. Powell

Antipurinergic therapy corrects the autism-like features in the Fragile X (Fmr1 knockout) mouse model

Jane C. Naviaux, Lin Wang, Kefeng Li et al. · Molecular Autism · 2015 · 278 citations · Full text

Prepulse inhibition and genetic mouse models of schizophrenia

Susan B. Powell, Xianjin Zhou, Mark A. Geyer · Behavioural Brain Research · 2009 · 217 citations · Full text

Psychiatry, Psychotic Disorder, Psychiatric Genetics +8

Differential contributions of serotonin receptors to the behavioral effects of indoleamine hallucinogens in mice

Adam L. Halberstadt, Liselore Koedood, Susan B. Powell et al. · Journal of Psychopharmacology · 2010 · 205 citations

5-Hydroxytryptamine2A Receptor Inverse Agonists as Antipsychotics

David M. Weiner, Ethan S. Burstein, N. T. Nash et al. · Journal of Pharmacology and Experimental Therapeutics · 2001 · 201 citations

Pharmacological and Behavioral Profile of N-(4-Fluorophenylmethyl)-N-(1-methylpiperidin-4-yl)-N′-(4-(2-methylpropyloxy)phenylmethyl) Carbamide (2 R,3 R)-Dihydroxybutanedioate (2:1) (ACP-103), a Novel 5-Hydroxytryptamine2A Receptor Inverse Agonist

Kimberly E. Vanover, David M. Weiner, Malath Makhay et al. · Journal of Pharmacology and Experimental Therapeutics · 2006 · 196 citations · Full text